ArticlePLOS digital health2026
Assessing body composition via a smartphone computer vision application: High repeatability but method-dependent agreement compared with BODPOD and Inbody.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The AI Revolution in Virtual Try-Ons: A Means-End Chain Model Perspective.Behavioral sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate assessment of body composition is essential for monitoring health status, fitness progress, and disease risk. Traditional methods such as air displacement plethysmography (BODPOD) and bioelectrical impedance analysis (BIA) are widely used to estimate body fat percentage (BF%), fat mass (FM), and fat-free mass (FFM), but can be costly or inaccessible. Smartphone applications utilizing computer vision (CV) offer a promising alternative. This study evaluated the relative agreement and same session repeatability under standardized conditions of a smartphone-based CV application (CVapp) compared to BODPOD and the InBody BIA device. Forty-nine adults (ages 18-70; 29 females, 27 racial and ethnic minority participants) completed two consecutive measurements using BODPOD, InBody, and CVapp in a single session. Differences in BF%, FM, and FFM estimates were analyzed using repeated-measures ANOVA. Agreement metrics included mean absolute error (MAE), root mean square error (RMSE), concordance correlation coefficients (CCC), and Bland-Altman analysis. Subgroup analyses examined differences by sex and minority status. The CVapp yielded higher BF% (mean=+2.2%, P = 0.004) and FM (+1.5 kg, p = 0.015) compared to BODPOD, and lower FFM than InBody (mean=-1.84 kg, p = 0.043). The CVapp agreement with BODPOD (MAE = 4.0, RMSE = 5.0, CCC = 0.86) was weaker than with the InBody (MAE = 3.3, RMSE = 4.3, CCC = 0.89), with wider limits of agreement. All methods showed excellent within session repeatability under standardized conditions (ICC > 0.99). A significant Sex×Method interaction was observed for BF% (p < 0.001), FM (p < 0.001), and FFM (p = 0.013), with females showing greater overestimation of BF% (mean=+3.9%) and FM (mean=+2.7 kg, p < 0.001), and underestimation of FFM (mean=-2.5 kg, p < 0.001) by the CVapp. Among Minority participants, BF% and FM estimates from the CVapp were significantly higher than BODPOD (mean=+2.7%, p = 0.009; mean=+1.8 kg, p = 0.031), and FFM was lower (mean=-1.8 kg, p = 0.035), with significant Method×Minority Group interactions for FM and FFM (p < 0.03). These findings support cautious use of CVapp-derived values for within-person monitoring under similar conditions but suggest they should not be treated as interchangeable with established comparator methods or used as standalone diagnostic estimates of body composition. Future efforts should address the need for more accurate, transparent, and equitable algorithms that are validated across diverse populations and testing contexts.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.